P2RX7 and graft versus host disease: To investigate the role of donor P2X7 in a humanised mouse model of GVHD, NSG mice were injected with 10 × 106 hPBMCs at Day 0 followed by 100 μg of the anti-hP2X7 or isotype control mAb every second day from Days 0–8.